Hallmarks of the ageing lung

European Respiratory Journal

Volumn 45, Issue 3, 2015, Pages 807-827

  Meiners, Silke ^a,b   Eickelberg, Oliver ^a,b   Königshoff, Melanie ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b German Center for Lung Research (DZL)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CELL AGING; CELL COMMUNICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA MODIFICATION; EPIGENETICS; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; GENOMIC INSTABILITY; HUMAN; INCIDENCE; LIFESPAN; LUNG ALVEOLUS CELL; LUNG CANCER; LUNG CARCINOGENESIS; NONHUMAN; NUTRITIONAL DISORDER; ONSET AGE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN HOMEOSTASIS; RISK ASSESSMENT; RISK FACTOR; STEM CELL; TELOMERE; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGING; CELL AGING; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIGNAL TRANSDUCTION;

EID: 84923993482     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00186914     Document Type: Article

References (293)

1. Kirkwood TBL. Understanding the odd science of ageing. Cell 2005; 120: 437-447.
2. Jeck WR, Siebold AP, Sharpless NE. Review: a meta-analysis of GWAS and age-associated diseases. Ageing Cell 2012; 11: 727-731.
3. Jones OR, Scheuerlein A, Salguero-Gómez R, et al. Diversity of ageing across the tree of life. Nature 2014; 505: 169-173.
4. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957; 11: 398-411.
5. Blagosklonny MV. Revisiting the antagonistic pleiotropy theory of ageing: TOR-driven program and quasi-program. Cell Cycle 2010; 9: 3151-3156.
6. Lezzerini M, Smith RL, Budovskaya Y. Developmental drift as a mechanism for ageing: lessons from nematodes. Biogerontology 2013; 14: 693-701.
7. Liu H, Fergusson MM, Castilho RM, et al. Augmented Wnt signaling in a mammalian model of accelerated ageing. Science 2007; 317: 803-806.
8. Hoffmeyer K, Raggioli A, Rudloff S, et al. Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. Science 2012; 336: 1549-1554.
9. Castilho RM, Squarize CH, Chodosh LA, et al. mTOR mediates Wnt-induced epidermal stem cell exhaustion and ageing. Cell Stem Cell 2009; 5: 279-289.
10. Yu B, Chang J, Liu Y, et al. Wnt4 signaling prevents skeletal ageing and inflammation by inhibiting nuclear factor-êB. Nat Med 2014; 9: 1009-1017.
11. Königshoff M, Kramer M, Balsara N, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009; 119: 772-787.
12. Kneidinger N, Yildirim AÖ, Callegari J, et al. Activation of the WNT/β-catenin pathway attenuates experimental emphysema. Am J Respir Crit Care Med 2011; 183: 723-733.
13. Kirkwood TB. Evolution of ageing. Nature 1977; 270: 301-304.
14. Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking ageing to chronic disease. Cell 2014; 159: 709-713.
15. International Agency for Research on Cancer. 2012. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr Date last accessed: January 9, 2015. Date last updated: December 7, 2014.
16. Rycroft CE, Heyes A, Lanza L, et al. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 2012; 7: 457-494.
17. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002; 51: 1-16.
18. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810-816.
19. Miniño AM. Death in the United States 2011. NCHS Data Brief 2013; 115: 1-8.
20. López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of ageing. Cell 2013; 153: 1194-1217.
21. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and ageing. Nat Med 2006; 12: 1133-1138.
22. Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013; 493: 338-345.
23. Wu JJ, Quijano C, Chen E, et al. Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy. Ageing (Albany NY) 2009; 1: 425-437.
24. Campisi J. Senescent cells, tumor suppression, and organismal ageing: good citizens, bad neighbors. Cell 2005; 120: 513-522.
25. Rubinsztein DC, Mariño G, Kroemer G. Autophagy and ageing. Cell 2011; 146: 682-695.
26. Martins I, Galluzzi L, Kroemer G. Hormesis, cell death and ageing. Ageing (Albany NY) 2011; 3: 821-828.
27. Muñoz-Espín D, Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol 2014; 15: 482-496.
28. Kourtis N, Tavernarakis N. Cellular stress response pathways and ageing: intricate molecular relationships. EMBO J 2011; 30: 2520-2531.
29. Haigis MC, Yankner BA. The ageing stress response. Mol Cell 2010; 40: 333-344.
30. Finkel T. Telomeres and mitochondrial function. Circ Res 2011; 108: 903-904.
31. Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science 2010; 330: 612-616.
32. Rando TA, Chang HY. Ageing, rejuvenation, and epigenetic reprogramming: resetting the ageing clock. Cell 2012; 148: 46-57.
33. Jones DL, Rando TA. Emerging models and paradigms for stem cell ageing. Nat Cell Biol 2011; 13: 506-512.
34. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999; 13: 197-205.
35. Calvi CL, Podowski M, Alessio FRD, et al. Critical Transition in Tissue Homeostasis Accompanies Murine Lung Senescence. PLoS One 2011; 6. e20712.
36. Fukuchi Y. The ageing lung and chronic obstructive pulmonary disease: similarity and difference. Proc Am Thorac Soc 2009; 6: 570-572.
37. Teramoto S, Fukuchi Y, Uejima Y, et al. A novel model of senile lung: senescence-accelerated mouse (SAM). Am J Respir Crit Care Med 1994; 150: 238-244.
38. Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, ageing, and smoking. Am J Respir Crit Care Med 2006; 174: 530-537.
39. Sato A, Hirai T, Imura A, et al. Morphological mechanism of the development of pulmonary emphysema in klotho mice. Proc Natl Acad Sci USA 2007; 104: 2361-2365.
40. Alder JK, Guo N, Kembou F, et al. Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 2011; 184: 904-912.
41. Zhou S, Wright JL, Liu J, et al. Ageing does not enhance experimental cigarette smoke-induced COPD in the mouse. PLoS One 2013; 8: e71410.
42. Moskalev AA, Shaposhnikov MV, Plyusnina EN, et al. The role of DNA damage and repair in ageing through the prism of Koch-like criteria. Ageing Res Rev 2013; 12: 661-684.
43. German J. Bloom's Syndrome. I. Genetical and clinical observations in the first twenty-seven patients. Am J Hum Genet. 1968; 21: 196-227.
44. Gordon LB, Rothman FG, López-Otín C, et al. Progeria: a paradigm for translational medicine. Cell 2014; 156: 400-407.
45. Aoshiba K, Zhou F, Tsuji T, et al. DNA damage as a molecular link in the pathogenesis of COPD in smokers. Eur Respir J 2012; 39: 1368-1376.
46. Makris D, Tzanakis N, Damianaki A, et al. Microsatellite DNA instability and COPD exacerbations. Eur Respir J 2008; 32: 612-618.
47. Tzortzaki EG, Dimakou K, Neofytou E, et al. Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. Chest 2012; 141: 1243-1250.
48. Caramori G, Adcock IM, Casolari P, et al. Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax 2011; 66: 521-527.
49. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-740.
50. Amsellem V, Gary-Bobo G, Marcos E, et al. Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184: 1358-1366.
51. Morlá M, Busquets X, Pons J, et al. Telomere shortening in smokers with and without COPD. Eur Respir J 2006; 27: 525-528.
52. Tsuji T, Aoshiba K, Nagai A. Cigarette smoke induces senescence in alveolar epithelial cells. Am J Respir Cell Mol Biol 2004; 31: 643-649.
53. Albrecht E, Sillanpää E, Karrasch S, et al. Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J 2014; 43: 983-992.
54. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest 2013; 123: 996-1002.
55. Nunes H, Monnet I, Kannengiesser C, et al. Is telomeropathy the explanation for combined pulmonary fibrosis and emphysema syndrome?: report of a family with TERT mutation. Am J Respir Crit Care Med. 2014; 189: 753-754.
56. Imai S-I, Guarente L. NAD(+) and sirtuins in ageing and disease. Trends Cell Biol 2014; 24: 464-471.
57. Yang IV, Schwartz DA. Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med 2011; 183: 1295-1301.
58. Wan ES, Qiu W, Baccarelli A, et al. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet 2012; 21: 3073-3082.
59. Sood A, Petersen H, Blanchette CM, et al. Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med 2010; 182: 1098-1104.
60. Vucic EA, Chari R, Thu KL, et al. DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways. Am J Respir Cell Mol Biol 2014; 50: 912-922.
61. Qiu W, Baccarelli A, Carey VJ, et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 2012; 185: 373-381.
62. Sundar IK, Yao H, Rahman I. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal 2013; 18: 1956-1971.
63. Barnes PJ. Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 2009; 71: 451-464.
64. Powers ET, Morimoto RI, Dillin A, et al. Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 2009; 78: 959-991.
65. Meiners S, Greene CM. Protein quality control in lung disease: it's all about cloud networking. Eur Respir J 2014; 44: 846-849.
66. Greene CM, McElvaney NG. Protein misfolding and obstructive lung disease. Proc Am Thorac Soc 2010; 7: 346-355.
67. Gooptu B, Ekeowa UI, Lomas DA. Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. Eur Respir J 2009; 34: 475-488.
68. Meiners S, Eickelberg O. What shall we do with the damaged proteins in lung disease? Ask the proteasome! Eur Respir J 2012; 40: 1260-1268.
69. Ryter SW, Chen Z-H, Kim HP, et al. Autophagy in chronic obstructive pulmonary disease: homeostatic or pathogenic mechanism? Autophagy 2009; 5: 235-237.
70. Hengstermann A, Müller T. Endoplasmic reticulum stress induced by aqueous extracts of cigarette smoke in 3T3 cells activates the unfolded-protein-response-dependent PERK pathway of cell survival. Free Radic Biol Med 2008; 44: 1097-1107.
71. Geraghty P, Wallace A, D'Armiento JM. Induction of the unfolded protein response by cigarette smoke is primarily an activating transcription factor 4-C/EBP homologous protein mediated process. Int J Chron Obstruct Pulmon Dis 2011; 6: 309-319.
72. Kenche H, Baty CJ, Vedagiri K, et al. Cigarette smoking affects oxidative protein folding in endoplasmic reticulum by modifying protein disulfide isomerase. FASEB J 2013; 27: 965-977.
73. Somborac-Bacura A, van der Toorn M, Franciosi L, et al. Cigarette smoke induces endoplasmic reticulum stress response and proteasomal dysfunction in human alveolar epithelial cells. Exp Physiol 2013; 98: 316-325.
74. Dransfield MT, Wilhelm AM, Flanagan B, et al. Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. Chest 2013; 144: 498-506.
75. Raju SV, Jackson PL, Courville CA, et al. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med 2013; 188: 1321-1330.
76. Van Rijt SH, Keller IE, John G, et al. Acute cigarette smoke exposure impairs proteasome function in the lung. Am J Physiol Lung Cell Mol Physiol 2012; 303: L814-L823.
77. Kipen HM, Gandhi S, Rich DQ, et al. Acute decreases in proteasome pathway activity after inhalation of fresh diesel exhaust or secondary organic aerosol. Environ Health Perspect 2011; 119: 658-663.
78. Malhotra D, Thimmulappa R, Vij N, et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med 2009; 180: 1196-1207.
79. Chen Z-H, Lam HC, Jin Y, et al. Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc Natl Acad Sci USA 2010; 107: 18880-18885.
80. Lam HC, Cloonan SM, Bhashyam AR, et al. Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction. J Clin Invest 2013; 123: 5212-5230.
81. Mizumura K, Cloonan SM, Haspel JA, et al. The emerging importance of autophagy in pulmonary diseases. Chest 2012; 142: 1289-1299.
82. Kenyon CJ. The genetics of ageing. Nature 2010; 464: 504-512.
83. Cheng C-W, Adams GB, Perin L, et al. Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression. Cell Stem Cell 2014; 14: 810-823.
84. Colman RJ, Beasley TM, Kemnitz JW, et al. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun 2014; 5: 3557.
85. Yoshida T, Mett I, Bhunia AK, et al. Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med 2010; 16: 767-773.
86. Eijkelenboom A, Burgering BMT. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 2013; 14: 83-97.
87. Yao H, Chung S, Hwang J, et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. 2012; 122: 2032-2045.
88. Hwang J, Rajendrasozhan S, Yao H, et al. FOXO3 deficiency leads to increased susceptibility to cigarette smoke-induced inflammation, airspace enlargement, and chronic obstructive pulmonary disease. J Immunol 2011; 187: 987-998.
89. Ganesan S, Unger BL, Comstock AT, et al. Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A. Thorax 2013; 68: 131-141.
90. Warr MR, Binnewies M, Flach J, et al. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 2013; 494: 323-327.
91. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and ageing. Cell 2005; 120: 483-495.
92. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006; 28: 219-242.
93. Ballweg K, Mutze K, Königshoff M, et al. Cigarette smoke extract affects mitochondrial function in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2014; 307: L895-L907.
94. Hara H, Araya J, Ito S, et al. Mitochondrial fragmentation in cigarette smoke induced-bronchial epithelial cell senescence. Am J Physiol Lung Cell Mol Physiol 2013; 305: L737-L746.
95. Mizumura K, Cloonan SM, Nakahira K, et al. Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J Clin Invest 2014; 124: 3987-4003.
96. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9: 81-94.
97. Hara H, Araya J, Takasaka N, et al. Involvement of creatine kinase B in cigarette smoke-induced bronchial epithelial cell senescence. Am J Respir Cell Mol Biol 2012; 46: 306-312.
98. Nyunoya T, Monick MM, Klingelhutz A, et al. Cigarette smoke induces cellular senescence. Am J Respir Cell Mol Biol 2006; 35: 681-688.
99. Nyunoya T, Monick MM, Klingelhutz AL, et al. Cigarette smoke induces cellular senescence via Werner's syndrome protein down-regulation. Am J Respir Crit Care Med 2009; 179: 279-287.
100. Fujii S, Hara H, Araya J, et al. Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease. Oncoimmunology 2012; 1: 630-641.
101. Sorrentino JA, Krishnamurthy J, Tilley S, et al. p16 INK4a reporter mice reveal age-promoting effects of environmental toxicants. J Clin Investig 2014; 124: 169-173.
102. Signer RAJ, Morrison SJ. Mechanisms that regulate stem cell ageing and life span. Cell Stem Cell 2013; 12: 152-165.
103. Sánchez Alvarado A, Yamanaka S. Rethinking differentiation: stem cells, regeneration, and plasticity. Cell 2014; 157: 110-119.
104. Behrens A, van Deursen JM, Rudolph KL, et al. Impact of genomic damage and ageing on stem cell function. Nat Cell Biol 2014; 16: 201-207.
105. Ruzankina Y, Asare A, Brown EJ. Replicative stress, stem cells and ageing. Mech Ageing Dev 129: 460-466.
106. Ganuza M, Sáiz-Ladera C, Cañamero M, et al. Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature ageing due to adult stem cell exhaustion. EMBO J 2012; 31: 2498-2510.
107. Richardson RB. Age-specific bone tumour incidence rates are governed by stem cell exhaustion influencing the supply and demand of progenitor cells. Mech Ageing Dev 2014; 139: 31-40.
108. Boyette LB, Tuan RS. Adult stem cells and diseases of ageing. J Clin Med 2014; 3: 88-134.
109. Stripp BR, Reynolds SD. Maintenance and repair of the bronchiolar epithelium. Proc Am Thorac Soc 2008; 5: 328-333.
110. Hogan BLM, Barkauskas CE, Chapman HA, et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell 2014; 15: 123-138.
111. Rock J, Königshoff M. Endogenous lung regeneration: potential and limitations. Am J Respir Crit Care Med 2012; 186: 1213-1219.
112. Kotton DN, Morrisey EE. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med 2014; 20: 822-832.
113. Rawlins EL, Giangreco A. The best laid schemes of airway repair. Eur Respir J 2014; 44: 299-301.
114. Barkauskas CE, Cronce MJ, Rackley CR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 2013; 123: 3025-3036.
115. Shaykhiev R, Crystal RG. Basal cell origins of smoking-induced airway epithelial disorders. Cell Cycle 2014; 13: 341-342.
116. Ryan DM, Vincent TL, Salit J, et al. Smoking dysregulates the human airway basal cell transcriptome at COPD risk locus 19q13.2. PLoS One 2014; 9: e88051.
117. Issa J-P. Ageing and epigenetic drift: a vicious cycle. J Clin Invest 2014; 124: 24-29.
118. Paschalaki KE, Starke RD, Hu Y, et al. Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence. Stem Cells 2013; 31: 2813-2826.
119. Brittan M, Hoogenboom MM, Padfield GJ, et al. Endothelial progenitor cells in patients with chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2013; 305: L964-L969.
120. Janssen WJ, Yunt ZX, Muldrow A, et al. Circulating hematopoietic progenitor cells are decreased in COPD. COPD 2014; 11: 277-289.
121. Paxson JA, Gruntman AM, Davis AM, et al. Age dependence of lung mesenchymal stromal cell dynamics following pneumonectomy. Stem Cells Dev 2013; 22: 3214-3225.
122. Bustos ML, Huleihel L, Kapetanaki MG, et al. Ageing mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response. Am J Respir Crit Care Med 2014; 189: 787-798.
123. Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 2007; 4: 512-521.
124. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378: 1015-1026.
125. Meyer KC. The role of immunity and inflammation in lung senescence and susceptibility to infection in the elderly. Semin Respir Crit Care Med 2010; 31: 561-574.
126. Shapiro SD, Ingenito EP. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol 2005; 32: 367-372.
127. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 2003; 54: 113-129.
128. Churg A, Zhou S, Wright JL. Series "matrix metalloproteinases in lung health and disease': Matrix metalloproteinases in COPD. Eur Respir J 2012; 39: 197-209.
129. Yao H, Hwang J, Sundar IK, et al. SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD. Am J Physiol Lung Cell Mol Physiol 2013; 305: L615-L624.
130. Ramnath NWM, van de Luijtgaarden KM, van der Pluijm I, et al. Extracellular matrix defects in aneurysmal fibulin-4 mice predispose to lung emphysema. PLoS One 2014; 9: e106054.
131. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
132. Garinis GA, Van Der Horst GTJ, Vijg J, et al. REVIEW DNA damage and ageing : new-age ideas for an age-old problem. Nat Cell Biol 2008; 10: 1241-1247.
133. Ohnishi S, Fujimoto M, Oide T, et al. Primary lung cancer associated with Werner syndrome. Geriatr Gerontol Int 2010; 10: 319-323.
134. Matakidou A, el Galta R, Webb EL, et al. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet 2007; 16: 2333-2340.
135. Lin Z, Zhang X, Tuo J, et al. A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer. Hum Mutat 2008; 29: 113-122.
136. Uehara Y, Ikehata H, Furuya M, et al. XPC is involved in genome maintenance through multiple pathways in different tissues. Mutat Res 2009; 670: 24-31.
137. Capell BC, Collins FS. Human laminopathies: nuclei gone genetically awry. Nat Rev Genet 2006; 7: 940-952.
138. Hatch EM, Fischer AH, Deerinck TJ, et al. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 2013; 154: 47-60.
139. Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 2012; 13: 878-890.
140. Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406: 641-645.
141. Greenberg RA, Chin L, Femino A, et al. Short dysfunctional telomeres impair tumorigenesis in the INK4aÄ2/3 cancer-prone mouse. Cell 1999; 97: 515-525.
142. Stewart SA, Bertuch AA. The role of telomeres and telomerase in cancer research. Cancer Res 2010; 70: 7365-7371.
143. Perera SA, Maser RS, Xia H, et al. Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer. Carcinogenesis 2008; 29: 747-753.
144. Frías C, García-Aranda C, De Juan C, et al. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer. Lung Cancer 2008; 60: 416-425.
145. Lantuéjoul S, Salon C, Soria J-C, et al. Telomerase expression in lung preneoplasia and neoplasia. Int J Cancer 2007; 120: 1835-1841.
146. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011; 11: 726-734.
147. You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012; 22: 9-20.
148. Jakopovic M, Thomas A, Balasubramaniam S, et al. Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy. Front Oncol 2013; 3: 261.
149. Smith LT, Lin M, Brena RM, et al. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci USA 2006; 103: 982-987.
150. Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 2004; 4: 966-977.
151. Hetz C, Chevet E, Harding HP. Targeting the unfolded protein response in disease. Nat Rev Drug Discov 2013; 12: 703-719.
152. Marcinak SJ, Ron D. The unfolded protein response in lung disease. Proc Am Thorac Soc 2010; 7: 356-362.
153. Jorgensen E, Stinson A, Shan L, et al. Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer 2008; 8: 229.
154. Mah LY, Ryan KM. Autophagy and cancer. Cold Spring Harb Perspect Biol 2012; 4: a008821.
155. Rao S, Tortola L, Perlot T, et al. A dual role for autophagy in a murine model of lung cancer. Nat Commun 2014; 5: 3056.
156. Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 2012; 11: 709-730.
157. Weathington NM, Mallampalli RK. Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest 2014; 124: 6-12.
158. Shen M, Schmitt S, Buac D, et al. Targeting the ubiquitin-proteasome system for cancer therapy. Expert Opin Ther Targets 2013; 17: 1091-1108.
159. Richardson PG, Mitsiades C, Hideshima T, et al. Proteasome inhibition in the treatment of cancer. Cell 2005; 4: 290-296.
160. Suzuki E, Demo S, Deu E, et al. Molecular mechanisms of bortezomib resistant adenocarcinoma cells. PLoS One 2011; 6: e27996.
161. De Wilt LH, Jansen G, Assaraf YG, et al. Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer. Biochem Pharmacol 2012; 83: 207-217.
162. Oerlemans R, Franke NE, Assaraf YG, et al. Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood 2008; 112: 2489-2499.
163. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell; 2011; 144: 646-674.
164. Cooper WA, Lam DCL, O'Toole SA, et al. Molecular biology of lung cancer. J Thorac Dis 2013; 5: Suppl. 5, S479-S490.
165. Massarelli E, Papadimitrakopoulou VA. Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer. J Thorac Oncol 2012; 7: S379-S382.
166. Ekman S, Wynes MW, Hirsch FR. The mTOR pathway in lung cancer and implications for therapy and biomarker analysis. J Thorac Oncol 2012; 7: 947-953.
167. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 2008; 18: 165-173.
168. Aravamudan B, Thompson MA, Pabelick CM, et al. Mitochondria in lung diseases. Expert Rev Respir Med 2013; 7: 631-646.
169. Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436: 642.
170. Saab R. Senescence and pre-malignancy: how do tumors progress? Semin Cancer Biol 2011; 21: 385-391.
171. Nyunoya T, Mebratu Y, Contreras A, et al. Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung. Am J Respir Cell Mol Biol 2014; 50: 471-482.
172. Kraunz KS, Nelson HH, Lemos M, et al. Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer. Int J Cancer 2006; 118: 1364-1369.
173. Ruzankina Y, Brown EJ. Relationships between stem cell exhaustion, tumour suppression and ageing. Br J Cancer 2007; 97: 1189-1193.
174. Lara-Padilla E, Caceres-Cortes JR. On the nature of the tumor-initiating cell. Curr Stem Cell Res Ther 2012; 7: 26-35.
175. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
176. Wang A, Chen L, Pu K, et al. Identification of stem-like cells in non-small cell lung cancer cells with specific peptides. Cancer Lett 2014; 351: 100-107.
177. Eramo A, Haas TL, De Maria R. Lung cancer stem cells: tools and targets to fight lung cancer. Oncogene 2010; 29: 4625-4635.
178. Desai TJ, Brownfield DG, Krasnow MA. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 2014; 507: 190-194.
179. Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) 2013; 91: 411-429.
180. Gajewski TF, Schreiber H, Fu Y-X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013; 14: 1014-1022.
181. Van Overmeire E, Laoui D, Keirsse J, et al. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Front Immunol 2014; 5: 127.
182. Schumacher T, Bunse L, Pusch S, et al. A vaccine targeting mutant IDH1 induces antitumour immunity. Nature 2014; 512: 324-327.
183. Drake CG, Lipson EJ, Brahmer JR. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol 2014; 11: 24-37.
184. Ye J, Ma C, Hsueh EC, et al. Tumor-derived ãä regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence. J Immunol 2013; 190: 2403-2414.
185. Fulop T, Larbi A, Kotb R, et al. Ageing, immunity, and cancer. Discov Med 2011; 11: 537-550.
186. Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 2010; 22: 697-706.
187. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 2010; 18: 884-901.
188. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348.
189. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression and progression. 2004; 432: 332-337.
190. Naba A, Clauser KR, Hoersch S, et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 2012; 11: M111.014647.
191. Naba A, Clauser KR, Whittaker CA, et al. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer 2014; 14: 518.
192. Reticker-Flynn NE, Malta DFB, Winslow MM, et al. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat Commun 2012; 3: 1122.
193. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
194. Faner R, Rojas M, Macnee W, et al. Abnormal lung ageing in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012; 186: 306-313.
195. Selman M, Pardo A. Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis: an integral model. Am J Respir Crit Care Med 2014; 189: 1161-1172.
196. Safa WF, Lestringant GG, Frossard PM. X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation. Thorax 2001; 56: 891-894.
197. Schroeder SA, Swift M, Sandoval C, et al. Interstitial lung disease in patients with ataxia-telangiectasia. Pediatr Pulmonol 2005; 39: 537-543.
198. Vece TJ, Schecter MG, Gatti RA, et al. Rapid and progressive pulmonary fibrosis in 2 families with DNA repair deficiencies of undetermined etiology. J Pediatr 2012; 160: 700-702.e3.
199. Samara K, Zervou M, Siafakas NM, et al. Microsatellite DNA instability in benign lung diseases. Respir Med 2006; 100: 202-211.
200. Vassilakis DA, Sourvinos G, Spandidos DA, et al. Frequent Genetic Alterations at the Microsatellite Level in Cytologic Sputum Samples of Patients with. Am J Respir Crit Care Med 2000; 162: 1115-1119.
201. Tsang AR, Wyatt HDM, Ting NSY, et al. hTERT mutations associated with idiopathic pulmonary fibrosis affect telomerase activity, telomere length, and cell growth by distinct mechanisms. Ageing Cell 2012; 11: 482-490.
202. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet 2012; 13: 693-704.
203. Alder JK, Chen JJ-L, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 2008; 105: 13051-13056.
204. Armanios MY, Chen JJ-L, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007; 356: 1317-1326.
205. Cronkhite JT, Xing C, Raghu G, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 178: 729-737.
206. Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007; 104: 7552-7557.
207. Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013; 45: 613-620.
208. Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013; 45: 422-427.
209. Kropski JA, Mitchell DB, Markin C, et al. A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia. Chest 2014; 146: e1-e7.
210. Liu T, Chung MJ, Ullenbruch M, et al. Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. J Clin Invest 2007; 117: 3800-3809.
211. Le Saux CJ, Davy P, Brampton C, et al. A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis. PLoS One 2013; 8: e58423.
212. Liu T, Ullenbruch M, Young Choi Y, et al. Telomerase and telomere length in pulmonary fibrosis. Am J Respir Cell Mol Biol 2013; 49: 260-268.
213. Jiang X, Tsitsiou E, Herrick SE, et al. MicroRNAs and the regulation of fibrosis. FEBS J 2010; 277: 2015-2021.
214. Pandit KV, Corcoran D, Yousef H, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 182: 220-229.
215. Yang S, Banerjee S, de Freitas A, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol 2012; 180: 484-493.
216. Dakhlallah D, Batte K, Wang Y, et al. Epigenetic regulation of miR-17∼92 contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2013; 187: 397-405.
217. Rabinovich EI, Kapetanaki MG, Steinfeld I, et al. Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One 2012; 7: e33770.
218. Sanders YY, Ambalavanan N, Halloran B, et al. Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012; 186: 525-535.
219. Sanders YY, Pardo A, Selman M, et al. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol 2008; 39: 610-618.
220. Coward WR, Watts K, Feghali-Bostwick CA, et al. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol Cell Biol 2010; 30: 2874-2886.
221. Cisneros J, Hagood J, Checa M, et al. Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012; 303: L295-L303.
222. Coward WR, Watts K, Feghali-Bostwick CA, et al. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol Cell Biol 2009; 29: 4325-4339.
223. Nogee LM, Dunbar AE, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001; 344: 573-579.
224. Thomas AQ, Lane K, Phillips J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165: 1322-1328.
225. Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 2009; 84: 52-59.
226. Van Moorsel CHM, van Oosterhout MFM, Barlo NP, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am J Respir Crit Care Med 2010; 182: 1419-1425.
227. Tanjore H, Blackwell TS, Lawson WE. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012; 302: L721-L729.
228. Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease. J Cell Biol 2012; 197: 857-867.
229. Shore GC, Papa FR, Oakes SA. Signaling cell death from the endoplasmic reticulum stress response. Curr Opin Cell Biol 2011; 23: 143-149.
230. Lawson WE, Crossno PF, Polosukhin VV, et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am J Physiol Lung Cell Mol Physiol 2008; 294: L1119-L1126.
231. Korfei M, Ruppert C, Mahavadi P, et al. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 178: 838-846.
232. Lawson WE, Cheng D-S, Degryse AL, et al. Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs. Proc Natl Acad Sci USA 2011; 108: 10562-10567.
233. Kropski JA, Lawson WE, Blackwell TS. Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012; 302: L441-L444.
234. Torres-González E, Bueno M, Tanaka A, et al. Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis. Am J Respir Cell Mol Biol 2012; 46: 748-756.
235. Patel AS, Lin L, Geyer A, et al. Autophagy in idiopathic pulmonary fibrosis. PLoS One 2012; 7: e41394.
236. Araya J, Kojima J, Takasaka N, et al. Insufficient autophagy in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2013; 304: L56-L69.
237. Mutlu GM, Budinger GRS, Wu M, et al. Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling. Thorax 2012; 67: 139-146.
238. Krein PM, Winston BW. Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease. Chest 2002; 122: 289S-293S.
239. Pilewski JM, Liu L, Henry AC, et al. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol 2005; 166: 399-407.
240. Feghali-Bostwick CA. IGF-I: mediator of fibrosis or carcinogenesis? Am J Physiol Lung Cell Mol Physiol 2005; 288: L803-L804.
241. Choi J-E, Lee S-S, Sunde DA, et al. Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury. Am J Respir Crit Care Med 2009; 179: 212-219.
242. Noble PW, Barkauskas CE, Jiang D. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 2012; 122: 2756-2762.
243. Korfhagen TR, Le Cras TD, Davidson CR, et al. Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2009; 41: 562-572.
244. Nho RS, Hergert P, Kahm J, et al. Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix. Am J Pathol 2011; 179: 2420-2430.
245. Nho RS, Peterson M, Hergert P, et al. FoxO3a (Forkhead Box O3a) deficiency protects Idiopathic Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas. PLoS One 2013; 8: e61017.
246. Le Cras TD, Korfhagen TR, Davidson C, et al. Inhibition of PI3 K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Pathol 2010; 176: 679-686.
247. Kulkarni AA, Thatcher TH, Olsen KC, et al. PPAR-ã ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3 K/Akt pathway: implications for therapy of fibrosis. PLoS One 2011; 6: e15909.
248. White ES, Atrasz RG, Hu B, et al. Negative regulation of myofibroblast differentiation by PTEN (phosphatase and tensin homolog deleted on chromosome 10). Am J Respir Crit Care Med 2006; 173: 112-121.
249. White ES, Thannickal VJ, Carskadon SL, et al. Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med 2003; 168: 436-442.
250. Xia H, Khalil W, Kahm J, et al. Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 2010; 176: 2626-2637.
251. Miyoshi K, Yanagi S, Kawahara K, et al. Epithelial Pten controls acute lung injury and fibrosis by regulating alveolar epithelial cell integrity. Am J Respir Crit Care Med 2013; 187: 262-275.
252. Jain M, Rivera S, Monclus EA, et al. Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling. J Biol Chem 2013; 288: 770-777.
253. Hecker L, Vittal R, Jones T, et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009; 15: 1077-1081.
254. Hecker L, Logsdon NJ, Kurundkar D, et al. Reversal of persistent fibrosis in ageing by targeting nox4-nrf2 redox imbalance. Sci Transl Med 2014; 6: 231-247.
255. Herrera I, Cisneros J, Maldonado M, et al. Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption. J Biol Chem 2013; 288: 25964-25975.
256. Minagawa S, Araya J, Numata T, et al. Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2011; 300: L391-L401.
257. Aoshiba K, Tsuji T, Kameyama S, et al. Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury. Exp Toxicol Pathol 2013; 65: 1053-1062.
258. Citrin DE, Shankavaram U, Horton JA, et al. Role of type II pneumocyte senescence in radiation-induced lung fibrosis. J Natl Cancer Inst 2013; 105: 1474-1484.
259. Xu J, Gonzalez ET, Iyer SS, et al. Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow-derived cells can alter the outcome of lung injury in aged mice. J Gerontol A Biol Sci Med Sci 2009; 64: 731-739.
260. King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378: 1949-1961.
261. Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol 2011; 73: 413-435.
262. Chilosi M, Doglioni C, Murer B, et al. Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27: 7-18.
263. Malli F, Koutsokera A, Paraskeva E, et al. Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept. PLoS One 2013; 8: e53658.
264. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208: 1339-1350.
265. Bringardner BD, Baran CP, Eubank TD, et al. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 2008; 10: 287-301.
266. Fernandez IE, Eickelberg O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 2012; 380: 680-688.
267. Königshoff M, Eickelberg O. WNT signaling in lung disease: a failure or a regeneration signal? Am. J Respir Cell Mol Biol 2010; 42: 21-31.
268. Bauer Y, Tedrow J, de Bernard S, et al. A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol 2014 [In press DOI: 10.1165/rcmb.2013-0310OC].
269. Selman M, Pardo A, Kaminski N. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med 2008; 5: e62.
270. Gottardi CJ, Königshoff M. Considerations for targeting β-catenin signaling in fibrosis. Am J Respir Crit Care Med 2013; 187: 566-568.
271. Moshai EF, Wémeau-Stervinou L, Cigna N, et al. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice. Am J Respir Cell Mol Biol 2014; 51: 11-25.
272. Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987; 252: C1-C9.
273. Morales-Nebreda LI, Rogel MR, Eisenberg JL, et al. Lung specific loss of α3 laminin worsens bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2014 [In press DOI: 10.1165/rcmb.2014-0057OC].
274. Balestrini JL, Chaudhry S, Sarrazy V, et al. The mechanical memory of lung myofibroblasts. Integr Biol (Camb) 2012; 4: 410-421.
275. Wagner DE, Bonenfant NR, Parsons CS, et al. Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 2014; 35: 3281-3297.
276. Parker MW, Rossi D, Peterson M, et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest 2014; 124: 1622-1635.
277. Ghaedi M, Calle EA, Mendez JJ, et al. Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. J Clin Invest 2013; 123: 4950-4962.
278. Sueblinvong V, Neveu WA, Neujahr DC, et al. Aging promotes pro-fibrotic matrix production and increases fibrocyte recruitment during acute lung injury. Adv Biosci Biotechnol 2014; 5: 19-30.
279. Yang J, Wheeler SE, Velikoff M, et al. Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins. Am J Pathol 2013; 183: 1559-1570.
280. Popova AP, Bozyk PD, Goldsmith AM, et al. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol 2010; 298: L735-L743.
281. Marmai C, Sutherland RE, Kim KK, et al. Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2011; 301: L71-L78.
282. Yang KE, Kwon J, Rhim J-H, et al. Differential expression of extracellular matrix proteins in senescent and young human fibroblasts: a comparative proteomics and microarray study. Mol Cells 2011; 32: 99-106.
283. Hultström M, Leh S, Paliege A, et al. Collagen-binding proteins in age-dependent changes in renal collagen turnover: microarray analysis of mRNA expression. Physiol Genomics 2012; 44: 576-586.
284. Loffredo FS, Nikolova AP, Pancoast JR, et al. Heart failure with preserved ejection fraction: molecular pathways of the ageing myocardium. Circ Res 2014; 115: 97-107.
285. Dai D-F, Chen T, Johnson SC, et al. Cardiac ageing: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal 2012; 16: 1492-1526.
286. Glassock R, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int 2012; 82: 270-277.
287. Watt FM, Fujiwara H. Cell-extracellular matrix interactions in normal and diseased skin. Cold Spring Harb Perspect Biol 2011; 3: a005124.
288. Serrano AL, Muñoz-Cánoves P. Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res 2010; 316: 3050-3058.
289. Sokocevic D, Bonenfant NR, Wagner DE, et al. The effect of age and emphysematous and fibrotic injury on the re-cellularization of de-cellularized lungs. Biomaterials 2013; 34: 3256-3269.
290. Schiller HB, Hermann M-R, Polleux J, et al. β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments. Nat Cell Biol 2013; 15: 625-636.
291. Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol 2009; 10: 21-33.
292. Schiller HB, Fässler R. Mechanosensitivity and compositional dynamics of cell-matrix adhesions. EMBO Rep 2013; 14: 509-519.
293. Martino MM, Briquez PS, Güç E, et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 2014; 343: 885-888.